| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |